These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11099946)

  • 1. Polyglutamine stretches suppress transcription.
    Osborne LR
    Mol Med Today; 2000 Dec; 6(12):457-8. PubMed ID: 11099946
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanded polyglutamine stretches lead to aberrant transcriptional regulation in polyglutamine diseases.
    Shimohata T; Onodera O; Tsuji S
    Hum Cell; 2001 Mar; 14(1):17-25. PubMed ID: 11436350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference of CREB-dependent transcriptional activation by expanded polyglutamine stretches--augmentation of transcriptional activation as a potential therapeutic strategy for polyglutamine diseases.
    Shimohata M; Shimohata T; Igarashi S; Naruse S; Tsuji S
    J Neurochem; 2005 May; 93(3):654-63. PubMed ID: 15836624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides.
    Altschuler EL; Hud NV; Mazrimas JA; Rupp B
    J Pept Res; 1997 Jul; 50(1):73-5. PubMed ID: 9273890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription.
    Shimohata T; Nakajima T; Yamada M; Uchida C; Onodera O; Naruse S; Kimura T; Koide R; Nozaki K; Sano Y; Ishiguro H; Sakoe K; Ooshima T; Sato A; Ikeuchi T; Oyake M; Sato T; Aoyagi Y; Hozumi I; Nagatsu T; Takiyama Y; Nishizawa M; Goto J; Kanazawa I; Davidson I; Tanese N; Takahashi H; Tsuji S
    Nat Genet; 2000 Sep; 26(1):29-36. PubMed ID: 10973244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong aggregation and increased toxicity of polyleucine over polyglutamine stretches in mammalian cells.
    Dorsman JC; Pepers B; Langenberg D; Kerkdijk H; Ijszenga M; den Dunnen JT; Roos RA; van Ommen GJ
    Hum Mol Genet; 2002 Jun; 11(13):1487-96. PubMed ID: 12045202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyglutamine represses cAMP-responsive-element-mediated transcription without aggregate formation.
    Takahashi T; Nozaki K; Tsuji S; Nishizawa M; Onodera O
    Neuroreport; 2005 Feb; 16(3):295-9. PubMed ID: 15706239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using antibodies to analyze polyglutamine stretches.
    Brooks E; Arrasate M; Cheung K; Finkbeiner SM
    Methods Mol Biol; 2004; 277():103-28. PubMed ID: 15201452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of histidine interruption in mitigating the pathological effects of long polyglutamine stretches in SCA1: A molecular approach.
    Sen S; Dash D; Pasha S; Brahmachari SK
    Protein Sci; 2003 May; 12(5):953-62. PubMed ID: 12717018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.
    Nozaki K; Onodera O; Takano H; Tsuji S
    Neuroreport; 2001 Oct; 12(15):3357-64. PubMed ID: 11711886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway.
    Cong SY; Pepers BA; Zhou TT; Kerkdijk H; Roos RA; van Ommen GJ; Dorsman JC
    Neurobiol Dis; 2012 Jun; 46(3):673-81. PubMed ID: 22426400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dentatorubral-pallidoluysian atrophy (DRPLA)--discovery of the disease, DRPLA gene and the pathophysiology].
    Tsuji S
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1287-9. PubMed ID: 11464481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
    Bates EA; Victor M; Jones AK; Shi Y; Hart AC
    J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of neurodegeneration in polyglutamine diseases].
    Tsuji S
    Rinsho Shinkeigaku; 2003 Nov; 43(11):901-2. PubMed ID: 15152498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for polyproline II helical structure in short polyglutamine tracts.
    Chellgren BW; Miller AF; Creamer TP
    J Mol Biol; 2006 Aug; 361(2):362-71. PubMed ID: 16854433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
    Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulatory dysequilibrium of gene transcription and of nuclear transport in polyglutamine neuro-degeneration.
    Agius LM
    Med Hypotheses; 2003 Jun; 60(6):869-73. PubMed ID: 12699716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAMP-response element-binding protein and heat-shock protein 70 additively suppress polyglutamine-mediated toxicity in Drosophila.
    Iijima-Ando K; Wu P; Drier EA; Iijima K; Yin JC
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10261-6. PubMed ID: 16009936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions.
    Sharma D; Sharma S; Pasha S; Brahmachari SK
    FEBS Lett; 1999 Jul; 456(1):181-5. PubMed ID: 10452554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanisms of neurodegeneration in dentatorubral-pallidoluysian atrophy (DRPLA)].
    Tsuji S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1064-6. PubMed ID: 12235796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.